OPTIPHARMA AS

1448 DRØBAK

Finances

Share Ownership

Return on Equity

209,85 %

Current Ratio

1,24

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	23 991 000	22 482 000	15 021 000	9 554 000
Net Income	7 395 000	6 941 000	3 794 000	1 116 000
Total Assets	15 141 000	10 956 000	8 981 000	3 286 000
Total Equity	3 524 000	3 098 000	1 158 000	2 364 000

Income (NOK)	2022	2021	2020	2019
Revenue	23 991 000	22 482 000	15 021 000	9 554 000
Expenditure	14 440 000	13 607 000	10 115 000	8 142 000
Operating Profit	9 551 000	8 875 000	4 905 000	1 412 000
Financial Income	58 000	57 000	43 000	41 000
Financial Costs	127 000	33 000	84 000	19 000
Financial Balance	−69 000	24 000	−41 000	22 000
Earnings Before Tax	9 482 000	8 899 000	4 864 000	1 434 000
Tax	2 087 000	1 958 000	1 070 000	318 000
Net Income	7 395 000	6 941 000	3 794 000	1 116 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	779 000	1 591 000	506 000	619 000
Total Current Assets	14 362 000	9 365 000	8 476 000	2 667 000
Total Assets	15 141 000	10 956 000	8 981 000	3 286 000
Total Retained Equity	3 424 000	2 998 000	1 058 000	2 264 000
Total Equity	3 524 000	3 098 000	1 158 000	2 364 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	11 617 000	7 857 000	7 824 000	922 000
Total Equity and Debt	15 141 000	10 956 000	8 981 000	3 286 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	23 991 000	22 260 000	15 233 000	9 545 000
Other Income	0	222 000	−213 000	10 000
Revenue	23 991 000	22 482 000	15 021 000	9 554 000
Cost of Goods Sold	8 033 000	9 407 000	6 501 000	5 120 000
Salary Costs	3 901 000	2 565 000	2 552 000	1 835 000
Depreciation	374 000	434 000	200 000	299 000
Impairment	0	0	0	0
Expenditure	14 440 000	13 607 000	10 115 000	8 142 000
Operating Profit	9 551 000	8 875 000	4 905 000	1 412 000
Financial Income	58 000	57 000	43 000	41 000
Financial Costs	127 000	33 000	84 000	19 000
Financial Balance	−69 000	24 000	−41 000	22 000
Dividends	6 860 000	0	5 000 000	0
Net Income	7 395 000	6 941 000	3 794 000	1 116 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	100 000	48 000	37 000	41 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	679 000	1 543 000	469 000	579 000
Total Tangible Assets	679 000	1 543 000	469 000	579 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	779 000	1 591 000	506 000	619 000
Stock	3 268 000	907 000	371 000	192 000
Total Investments	0	0	0	0
Cash, Bank	6 709 000	7 475 000	6 871 000	1 997 000
Total Current Assets	14 362 000	9 365 000	8 476 000	2 667 000
Total Assets	15 141 000	10 956 000	8 981 000	3 286 000
Total Equity	3 524 000	3 098 000	1 158 000	2 364 000
Short-Term Group Debt	140 000	5 037 000	37 000	37 000
Total Long-Term Debt	0	0	0	0
Creditors	892 000	228 000	668 000	169 000
Unpaid Taxes	1 350 000	398 000	465 000	183 000
Dividends	6 860 000	0	5 000 000	0
Other Current Debt	267 000	225 000	588 000	184 000
Total Current Debt	11 617 000	7 857 000	7 824 000	922 000
Total Equity and Debt	15 141 000	10 956 000	8 981 000	3 286 000

Financial indicators	2022	2021	2020	2019
Return on Equity	209,85 %	224,05 %	327,63 %	47,21 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	39,81 %	39,48 %	32,65 %	14,78 %
Current Ratio	1,24	1,19	1,08	2,89
Quick Ratio	1,72	1,35	1,14	3,65
Equity Ratio	0,23	0,28	0,13	0,72
Gross Profit Margin	66,52 %	58,16 %	56,72 %	46,41 %